EU EMA report on progress towards 2030 clinical trial targets
- Increase in multinational trials: 19 multinational clinical trials have been authorised in addition to the historical average, bringing the EU closer to its goal of 500 extra multinational trials by the end of 2030.
- Faster recruitment timelines: currently, 40.5% of the total number of clinical trials recruit participants within 200 days from application submission. The EU target is 66% by 2030.
#UNITED KINGDOM#EUROPE#EQUITIES#EU SESSION#PHARMACEUTICALS#PHARMACEUTICALS (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#FTSE 100 INDEX#GSK PLC#GSK#GLOBAL EQUITIES